AI assistant
BIOGEN INC. — Director's Dealing 2011
Jul 21, 2011
30291_dirs_2011-07-21_faac79cf-669b-454e-a7f0-8035fc45a4ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2011-07-20
Reporting Person: SCANGOS GEORGE A (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-07-20 | Common Stock | S | 2640 | $105.9802 | Disposed | 64164 | Direct |
| 2011-07-20 | Common Stock | S | 3492 | $106.8946 | Disposed | 60672 | Direct |
| 2011-07-20 | Common Stock | S | 2415 | $105.937 | Disposed | 58257 | Direct |
| 2011-07-20 | Common Stock | S | 3800 | $106.8768 | Disposed | 54457 | Direct |
Footnotes
F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2: Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
F3: This represents the weighted average price for shares sold at a range between $105.62 (low) and $106.22 (high).
F4: This represents the weighted average price for shares sold at a range between $106.68 (low) and $106.99 (high).
F5: This represents the weighted average price for shares sold at a range between $105.57 (low) and $106.21 (high).
F6: This represents the weighted average price for shares sold at a range between $106.65 (low) and $106.99 (high).